Semisolid formulations containing dimethyl sulfoxide and α-tocopherol for the treatment of extravasation of antiblastic agents

Archives of Dermatological Research

Volumn 299, Issue 4, 2007, Pages 201-207

  Casiraghi, Antonella ^a   Ardovino, Paola ^b   Minghetti, Paola ^a   Botta, Cinzia ^b   Gattini, Arrigo ^b   Montanari, Luisa ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SANT ANNA HOSPITAL   (Italy)

Author keywords

tocopherol; Anthracycline extravasation; Dimethyl sulfoxide; Semisolid preparations for cutaneous application

Indexed keywords

2 PHENOXYETHANOL; AEROSIL; ALMOND OIL; ALPHA TOCOPHEROL; ANTHRACYCLINE DERIVATIVE; BUTYL PARABEN; CARBOMER; CETYLSTEARILIC ALCOHOL; CREMOPHOR; CYTOSTATIC AGENT; DERMOL; DIMETHYL SULFOXIDE; DRUG VEHICLE; ETHYL PARABEN; FATTYLAN; GERMALL 115; HYDROGENATED FAT; METHYL PARABEN; PROPYL PARABEN; SEPICIDE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; WATER OIL CREAM;

ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG FORMULATION; EPIDERMIS; EX VIVO STUDY; EXTRAVASATION; GEL; HUMAN; HUMAN TISSUE; HYDROGEL; HYDROPHILICITY; HYDROPHOBICITY; OINTMENT; PHASE SEPARATION; PRIORITY JOURNAL; SKIN IRRITATION; SKIN PERMEABILITY; SKIN PROTECTION; STRATUM CORNEUM;

ADMINISTRATION, TOPICAL; ALPHA-TOCOPHEROL; ANTHRACYCLINES; ANTIOXIDANTS; DIMETHYL SULFOXIDE; EMULSIONS; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; HUMANS; SKIN; SKIN ULCER;

EID: 34250745723     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-007-0746-9     Document Type: Article

References (30)

1. Allwood M, Stanley A, Wright P (eds) (1997) The cytotoxics handbook, 3rd edn. Radcliffe Medical Press, Oxford, pp 115-117
2. Ardovino P, Cassano A, Catelli P, Giordano M, Ostinelli L, Rizzi F (2000) Guida pratica di allestimento farmaci citotossici ed assistenza infermieristica al malato in terapia antiblastica. Centro di riferimento oncologico "Tullio Cairoli"-Como
3. Ardovino P, Giordano M, Lombardo R, Lomolino E, Rezzonico L, Rizzi F, Federici S (1999) Stravaso: revisione della letteratura e applicazione nella pratica clinica; II incontro di aggiornamento sugli aspetti farmacologici e tossicologici delle terapie oncologiche, Milano 29-30 giugno; Atti; ed.Medica Editoria e Diffusione Scientifica, pp 38-48
4. Bazzano C, De Angeles S, Kleist G, Macedo N (1996) Allergic contact dermatitis from topical vitamins A and E. Contact Dermatitis 35(4):261-262
5. Bekerecioglu M, Kutluhan A, Demirtas I, Karaayvaz M (1998) Prevention of adriamycin-induced skin necrosis with various free radical scavengers. J Surg Res 75(1):61-65
6. Bertelli G (1995) Prevention and management of extravasation of cytotoxic drugs. Drug Safety 12(4):244-255
7. Bertelli G, Gozza A, Forno GB, Vidili MG, Silvestro S, Venturini M, Del Mastro L, Garrone O, Rosso R, Dini D (1995) Topical dimethyl sulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study. J Clin Oncol 13(11):2851-2855
8. Bonnetblanc JM, Bordessoule D, Fayol J, Amici JM (1996) Treatment of accidental extravasation of antitumor agents with dimethyl sulfoxide and α-tocopherol. Ann Dermatol Venereol 123(10):640-643
9. Cal K (2006) How does the type of vehicle influence the in vitro skin absorption and elimination kinetics of terpenes? Arch Dermatol Res 297(7):311-315
10. Cal K, Krzyzaniak M (2006) Stratum corneum absorption and retention of linalool and terpinen-4-ol applied as gel or oily solution in humans. J Dermatol Sci 42(3):265-267
11. Carpenter JF, Dawson PE (1991) Quantitation of DMSO in solutions and tissues by HPLC. Cryobiology 28(3):210-215
12. Creus N, Mateu J, Masso J, Codina C, Ribas J (2002) Toxicity to topical dimethyl sulfoxide (DMSO) when used as an extravasation antidote. Pharm World Sci 24(5):175-176
13. de Lemos ML (2004) Role of dimethylsulfoxide for management of chemotherapy extravasation. J Oncol Pharm Pract 10(4):197-200
14. Dorr RT, Soble MJ, Liddil JD, Keller JH (1986) Mitomycin C skin toxicity studies in mice: reduced ulceration and altered pharmacokinetics with topical dimethyl sulfoxide. J Clin Oncol 4(9):1399-1404
15. Fenchel K, Karthaus M (2000) Supportive care in cancer patients. Recent developments. Cytotoxic drug extravasation. In: Antibiotics and chemotherapy. Karger, Basel, vol 50, pp 144-146
16. Lawrence HJ, Walsh D, Zapotowski KA, Denham A, Goodnight SH, Gandara DR (1989) Topical dimethyl sulfoxide may prevent tissue damage from anthracycline extravasation. Cancer Chemother Pharmacol 23(5):316-318
17. Lebredo L, Barrie R, Woltering E (1992) DMSO protects against adriamycin-induced tissue necrosis. J Surg Res 53(1):62-65
18. Lim PFC, Liu XY, Kang L, Ho PCL, Chan YW, Chan SY (2006) Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidol. Int J Pharm 311(1-2):157-164
19. Llinares ME, Bermúdez M, Fuster JL, Díaz MS, González CM (2005) Toxicity to topical dimethyl sulfoxide in a pediatric patient with anthracycline extravasation. Pediatr Hematol Oncol 22(1):49-52
20. Loth H (1991) Vehicular influence on transdermal drug penetration. Int J Pharm 68(1-3):1-10
21. Ludwig CU, Stoll HR, Obrecht JP (1987) Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and α-tocopherole. Eur J Cancer Clin Oncol 23(3):327-329
22. Mader I, Furst-Weber PR, Semenitz EI, Terkola R, Wassertheurer SM (2003) Extravasation of citotoxic agents. In: Compendium for prevention and management. Springer, Wien, pp 120-130
23. Minghetti P, Casiraghi A, Cilurzo F, Montanari L, Marazzi M, Falcone L, Donati V (1999) Comparison of different membranes with cultures of keratinocytes from man for percutaneous absorption of nitroglycerin. J Pharm Pharmacol 51(6):729-734
24. Muir M (1996) DMSO: many uses, much controversies. Altern Complement Ther 2(4):230-235
25. Olver IN, Aisner J, Hament A, Buchanan L, Bishop JF, Kaplan S (1988) A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation. J Clin Oncol 6(11):1732-1735
26. Pehr K, Forsey RR (1993) Why don't we use vitamin E in dermatology? Can Med Assoc J 149(9):1247-1253
27. Rangarajan M, Zatz JL (2001) Kinetics of permeation and metabolism of α-tocopherol and α-tocopheryl acetate in micro-Yucatan pig skin. J Cosmet Sci 52(1):35-50
28. Svingen BA, Powis G, Appel PL, Scott M (1981) Protection against adriamycin-induced skin necrosis in the rat by dimethyl sulfoxide and α-tocopherol. Cancer Res 41(9I):3395-3399
29. Svingen BA, Powis G, Appel PL, Scott M (1981) Protection by α-tocopherol and dimethyl sulfoxide (DMSO) against adriamycin induced skin ulcers in the rat. Res Commun Chem Pathol Pharmacol 32(1):189-192
30. Wagner H, Kostka KH, Adelhardt W, Schaefer UF (2004) Effects of various vehicles on the penetration of flufenamic acid into human skin. Eur J Pharm Biopharm 58(1):121-129